|
| Press Releases |
|
 |
|
| Wednesday, May 8, 2024 |
|
|
Lexaria Begins Dosing of Its Second GLP-1 Human Pilot Study |
| Lexaria Bioscience Corp. (Nasdaq: LEXX & LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces that human pilot study #2, GLP-1-H24-2, (the "Study") is underway and the first dosing visit for all nine study participants has already concluded. more info >> |
|
| Monday, May 6, 2024 |
|
|
Lexaria Announces New Research Program to Evaluate Mode of Action and Performance of DehydraTECH-GLP-1 Drugs |
| Lexaria Bioscience Corp. (Nasdaq: LEXX & LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces an applied research program to evaluate certain molecular characteristics of DehydraTECH processed with the glucagon-peptide 1 ("GLP-1") drug, semaglutide, related to its mode of action and performance. more info >> |
|
| Tuesday, April 16, 2024 |
|
|
Lexaria Receives Ethics Review Board Approval to Begin New GLP-1 Study |
| Lexaria Bioscience Corp. (Nasdaq: LEXX; LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces approval has been received from an independent third-party ethics review board, for human pilot study #2 (the "Study"), investigating GLP-1 drugs and DehydraTECH. more info >> |
|
| Tuesday, April 2, 2024 |
|
|
Lexaria Awarded New Patents |
| more info >> |
|
| Thursday, March 14, 2024 |
|
|
Lexaria Appoints Nelson Cabatuan as Chief Financial Officer |
| Lexaria Bioscience Corp. (Nasdaq: LEXX) (Nasdaq: LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces the appointment of Nelson Cabatuan, CPA, as Chief Financial Officer (CFO) effective immediately. more info >> |
|
| Thursday, March 7, 2024 |
|
|
Lexaria Awards Contract For Next GLP-1 Human Pilot Study |
| Lexaria Bioscience Corp. (Nasdaq: LEXX) (Nasdaq: LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces it has hired a contract research organization ("CRO") to perform the Company's second DehydraTECH-powered glucagon-like peptide 1 ("GLP-1") human pilot study #2 (the "Study"). more info >> |
|
| Tuesday, March 5, 2024 |
|
|
Lexaria to Begin Diabetes and Weight Loss Animal Study WEIGHT-A24-1 |
| more info >> |
|
| Monday, March 4, 2024 |
|
|
7% Weight Loss in Animals Supports Lexaria's Next 8-week Animal Study |
| more info >> |
|
| Friday, March 1, 2024 |
|
|
Lexaria Announces FDA Clearance for its Planned U.S. Phase 1b Hypertension Clinical Trial |
| Lexaria Bioscience Corp. (Nasdaq: LEXX; LEXXW), a global innovator in drug delivery platforms, announces that the U.S. Food and Drug Administration (FDA) has confirmed effectiveness as of February 28, 2024 of the Company's investigational new drug (IND) application thereby cleared for Lexaria to conduct its planned U.S. Phase 1b hypertension clinical trial HYPER-H23-1 utilizing DehydraTECH-CBD. more info >> |
|
| Saturday, February 17, 2024 |
|
|
Lexaria Announces Closing of $3.6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules |
| more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
Fujitsu collaborates with global suppliers in decarbonization initiative to exchange product-level primary data on CO2 emissions 
Nov 15, 2024 10:13 JST
|
|
|
DEFI to Launch 'DEFI Smart Pill Bottle' on Kickstarter
Nov 15, 2024 09:00 HKT/SGT
|
|
|
TANAKA Successfully Develops the World's First[1] Manufacturing Technology for Platinum Materials with Nano-Sized Crystal Grains
Nov 15, 2024 4:00 JST
|
|
|
The South Africa Manufacturing Show has announced the honorees for the esteemed Manufacturing 50 Awards
Nov 15, 2024 00:12 HKT/SGT
|
|
|
Lexaria Signs Contract for New DehydraTECH GLP-1 Biodistribution Study
Nov 14, 2024 22:10 HKT/SGT
|
|
|
Military Metals Announces LOI to Acquire Past-Producing Last Chance Antimony-Gold Property, near Round Mountain, Nevada
Nov 14, 2024 21:39 HKT/SGT
|
|
|
Explore the Next Era of DevOps at Exito's DevOps Summit in Dubai
Nov 14, 2024 21:04 HKT/SGT
|
|
|
MINGAONE Unveils Direct-to-Accommodation Red Ginseng Delivery Service for Foreign Tourists in Korea
Nov 14, 2024 20:00 HKT/SGT
|
|
|
myBillBook Leverages CleverTap to Elevate Customer Engagement and Drive Revenue Growth
Nov 14, 2024 20:00 JST
|
|
|
Doubleview Gold Corp Announces Closing of Private Placement for Total of $4,027,000
Nov 14, 2024 18:39 HKT/SGT
|
|
|
Disney Dream Reimagined! New Little Mermaid Wedding Ring Collection
Nov 14, 2024 14:00 HKT/SGT
|
|
|
Academic Labs, the Pioneering Crypto Platform Achieves a $300M at Its ICO
Nov 14, 2024 09:00 HKT/SGT
|
|
|
Blueberry Rebrand Reflects Exciting New Era for the Forex Company
Nov 14, 2024 09:00 HKT/SGT
|
|
|
ULVAC Launches Oil Rotary Vacuum Pump Gv135
Nov 14, 2024 10:00 JST
|
|
|
Femto Technologies Announces Third Quarter 2024 Financial Results
Nov 14, 2024 07:00 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
